[Drug treatment during pregnancy and state of the blood coagulation system in the newborn infant].
D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D006475:Vitamin K Deficiency Bleeding / Q000139:chemically induced*
D000925:Anticoagulants; D000927:Anticonvulsants; D005343:Fibrinolytic Agents
Medikamentoznoe lechenie vo vremia beremennosti i sostoianie koaguliruiushchikh svoĭstv krovi novorozhdennogo.